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List of abbreviations 
A2780     human ovarian carcinoma cell line 
A2780R    cisplatin-resistant human ovarian carcinoma cell line 
A498    renal cancer cell line 
A9opy     E-2-[1-(9-anthryl)-3-oxo-3-prop-2-enylpyridine]  
A9pyp    E-1-[9-anthryl)-3-(2-pyridyl)-2-propenone] 
Anal.    Elemental analysis 
ATP    Adenosinetriphosphate 
BAF A1    Bafilomicyn A1
BAPDA    N,N’-bis(anthracen-9-ylmethyl)propane-1,3-diamine 
BER    base-excision repair 
cbdca    1,1-cyclobutyldicarboxylic acid 
COSY    correlation spectroscopy 
DCM    Dichloromethane 
DMF    N,N’-dimethylformamide 
DMSO, dmso   dimethylsulfoxide (solvent), (ligand) 
DMEM    Dulbecco’s modified Eagle’s medium 
DNA    deoxyribonucleic acid 
eap    N,N’-diethyl-2,4-pentanediamine  
EC50  drug concentration that produces 50% of the maximum possible 
response 
Na2H2edta   Ethylenediamine tetraacetic acid disodium salt 
ESI-MS    Electrospray mass spectroscopy 
9-EtG    9-ethylguanine 
EVSA-T   a breast cancer cell line 
FAAS    Flameless Atomic Absorption Spectroscopy 
FCS    Fetal calf serum 
GSH    glutathione 
GS-X pump   glutathione S-conjugate export pump 
H226    a non-small lung cancer cell line 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HMG    High Mobility Group proteins 
IC50 concentration of a compound that induces 50% growth inhibition in 
cells compared to untreated cells 
ICP-OES Inductively Coupled Plasma Optical Emission Spectrometer 
IGROV    an ovarian cancer cell 
IR    infrared 
L-BSO    L-buthionine-S,R-sulfoximide 
M19    a melanoma cell line 
MCF-7    a breast cancer cell line 
MeOH    Methanol 
MMR    mismatch repair mechanism 
MRP    multi-drug resistance protein 
MT    metallothioneins 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide 
m/z    mass to charge ratio 
NER    nucleotide excision repair 
NMR    nuclear magnetic resonance 
NOESY    nuclear Overhauser effect spectroscopy 
PBS    phosphate buffered saline 
RPMI    Roswell Park Memorial Institute medium 
RF    resistance factor 
RNA    ribonucleic acid 
SDS    Sodium dodecyl sulfate
SRB    sulforhodamine B 
THF    Tetrahydrofuran 
Tris    2-amino-2-(hydroxymethyl)propane-1,3-diol 
UV    Ultra-Violet  
VEGF    vascular endothelial growth factor 
WIDR    a colon cancer cell line 
